Gut Dysbiosis and Neurodegeneration: Current Evidence and Future Directions
Year: 2026
Type: article
Abstract: Gut dysbiosis is increasingly associated with neurodegenerative diseases through the gut–brain axis. Altered gut microbiota may influence neuroinflammation, intestinal and blood–brain barrier integrity, oxidative stress, protein aggregation, and neurotransmitter signaling through microbial metabolites. This review summarizes the current evidence linking gut dysbiosis with Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease. It also discusses experimental models, microbiome-targeted therapies, multi-omics approaches, and artificial intelligence in microbiome research. Emerging strategies include dietary interventions, probiotics, prebiotics, postbiotics, fecal microbiota transplantation, phage therapy, precision microbiome therapy, and microbiome engineering. Despite promising findings, variability between individuals, lack of standardized methods, limited clinical evidence, and uncertainty regarding causality remain major challenges. Future research should emphasize standardized, longitudinal, and personalized approaches to establish the therapeutic potential of microbiome modulation in neurodegenerative diseases.
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: gut dysbiosis, neurodegenerative diseases, gut-brain axis, gut microbiota, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, neuroinflammation, blood-brain barrier, microbial metabolites, probiotics, prebiotics, postbiotics, fecal microbiota transplantation, phage therapy, microbiome engineering, dietary intervention, multi-omics
Open Access status: green
OpenAlex ID: W7235212336
